中国肺癌杂志2023，Vol.26Issue(6)：416-428,13.DOI:10.3779/j.issn.1009-3419.2023.102.19
MET 14外显子跳跃突变NSCLC靶向治疗专家共识
Expert Consensus on Targeted Therapy of NSCLC with MET Exon 14 Skipping Mutation
摘要
关键词
肺肿瘤/MET 14外显子跳跃突变/MET抑制剂/靶向治疗Key words
Lung neoplasms/MET exon 14 skipping mutation/MET inhibitors/Targeted therapy引用本文复制引用
中国老年保健协会肺癌专业委员会..MET 14外显子跳跃突变NSCLC靶向治疗专家共识[J].中国肺癌杂志,2023,26(6):416-428,13.基金项目
This paper was supprted by the grants from Tianjin Key Medical Discipline(Specialty)Construction Project(No.TJYXZDXK-061B)and Tianjin Health Science and Technology Project Key Disciplines(No.TJWJ2022XK005)(Both to Jun CHEN).本文受天津市医学重点建设学科-外科学其他学科(肺部肿瘤外科学)(No.TJYXZDXK-061B)和天津市卫生健康科技项目重点学科专项(No.TJWJ2022XK005)资助 （Specialty）
